Evidence map›Paper›PMID 19380587›Full record

ArticleThe Journal of biological chemistry2009

Conserved glutamate residues Glu-343 and Glu-519 provide mechanistic insights into cation/nucleoside cotransport by human concentrative nucleoside transporter hCNT3.

Melissa D Slugoski, Kyla M Smith, Amy M L Ng, Sylvia Y M Yao, Edward Karpinski, Carol E Cass, Stephen A Baldwin, James D Young

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Melissa D SlugoskiFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Kyla M SmithFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Amy M L NgFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Sylvia Y M YaoFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Edward KarpinskiFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada.
Carol E CassOncology, Membrane Protein Research Group, University of Alberta, Edmonton, Alberta T6G 2H7, Canada; Cross Cancer Institute, Edmonton, Alberta T6G 1Z2, Canada.
Stephen A BaldwinAstbury Centre for Structural Molecular Biology, Institute of Membrane and Systems Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
James D YoungFrom the Departments of Physiology, Edmonton, Alberta T6G 2H7, Canada. Electronic address: james.young@ualberta.ca.
Institute of Structural and Molecular Biology · GBUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human concentrative nucleoside transporter 3 (hCNT3) utilizes electrochemical gradients of both Na(+) and H(+) to accumulate pyrimidine and purine nucleosides within cells. We have employed radioisotope flux and electrophysiological techniques in combination with site-directed mutagenesis and heterologous expression in Xenopus oocytes to identify two conserved pore-lining glutamate residues (Glu-343 and Glu-519) with essential roles in hCNT3 Na(+)/nucleoside and H(+)/nucleoside cotransport. Mutation of Glu-343 and Glu-519 to aspartate, glutamine, and cysteine severely compromised hCNT3 transport function, and changes included altered nucleoside and cation activation kinetics (all mutants), loss or impairment of H(+) dependence (all mutants), shift in Na(+):nucleoside stoichiometry from 2:1 to 1:1 (E519C), complete loss of catalytic activity (E519Q) and, similar to the corresponding mutant in Na(+)-specific hCNT1, uncoupled Na(+) currents (E343Q). Consistent with close-proximity integration of cation/solute-binding sites within a common cation/permeant translocation pore, mutation of Glu-343 and Glu-519 also altered hCNT3 nucleoside transport selectivity. Both residues were accessible to the external medium and inhibited by p-chloromercuribenzene sulfonate when converted to cysteine.

Indexed as

4-ChloromercuribenzenesulfonateAnimalsBinding, CompetitiveCell MembraneConserved SequenceFemaleGlutamic AcidGuanosineHumansIn Vitro TechniquesIon TransportKineticsMembrane Transport ProteinsModels, MolecularMutagenesis, Site-DirectedNucleosides4-Chloromercuribenzenesulfonatecif nucleoside transporterGlutamic AcidGuanosineMembrane Transport ProteinsNucleosidesRecombinant ProteinsSodiumUridine

Identifiers

PMID19380587
PMCPMC2719363
OpenAlexW2067178440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.